Japan is pushing biotech startups harder, and peptide players like PeptiDream keep winning
Posted by weekendnate in Research & News - 2 points, 0 comments.
BioSpectrum Asia has a piece on Japan trying to seed another wave of biotech, and PeptiDream keeps coming up as the model student. For those who don't know, PeptiDream basically runs a peptide discovery platform that big pharma pays to use, and now it's sitting on a market cap north of $1.4 billion. The OriCiro exit to Moderna for $85M is also a nice data point that the pipeline actually produces exits, not just press releases.
What caught my eye is how the government angle is framing it. Japan is openly trying to engineer another cycle the way South Korea and China have. That matters because peptide drug discovery is wildly capital intensive, and most of the interesting early stage work still happens in APAC before anyone in the US licenses it.
Is anyone here actually following PeptiDream's pipeline, or is the more interesting story the smaller discovery shops that haven't been public yet?
Community discussion - research and educational context only. Not medical advice.